Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Tianeptine
Therapeutic Area : Neurology
Study Phase : Phase II
Sponsor : ABM Industries
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Tianeptine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Nervous System Diseases.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 25, 2023
Lead Product(s) : Tianeptine
Therapeutic Area : Neurology
Highest Development Status : Phase II
Sponsor : ABM Industries
Deal Size : Inapplicable
Deal Type : Inapplicable